HARMONIE Clinical Study – RSV Protection in Infants (NIHR, Sanofi, Labcorp Partnership) - Labcorp Drug Development - Sanofi

The HARMONIE clinical study is a large-scale European trial investigating protection against RSV, the leading cause of infant hospitalization globally. Conducted in collaboration with NIHR, Sanofi, and Labcorp Drug Development, the study aims to enroll over 20,000 infants across the UK, France, and Germany. As part of Labcorp’s Post Marketing Surveillance Department, Medical Contact Specialists analyze and report data related to adverse events (AE, SAE, NSAE). The study exemplifies multinational collaboration and compliance with rigorous post-market surveillance standards.

LANGUAGE SUPPORTED : FRENCH / ENGLISH / GERMAN